Find Publications

Search in all content

Filters for Publications

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Brian Druker
2020

Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia

Braun, T. P., Coblentz, C., Smith, B. M., Coleman, D. J., Schonrock, Z., Carratt, S. A., Callahan, R. L., Maniaci, B., Druker, B. J. & Maxson, J. E., Jun 16 2020, In : Proceedings of the National Academy of Sciences of the United States of America. 117, 24, p. 13670-13679 10 p.

Research output: Contribution to journalArticle

Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms

Joshi, S. K., Qian, K., Bisson, W. H., Watanabe-Smith, K., Huang, A., Bottomly, D., Traer, E., Tyner, J. W., McWeeney, S. K., Davare, M. A., Druker, B. J. & Tognon, C. E., Jun 11 2020, In : Blood. 135, 24, p. 2159-2170 12 p.

Research output: Contribution to journalArticle

ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia

Joshi, S. K., Keck, J. M., Eide, C. A., Bottomly, D., Traer, E., Tyner, J. W., McWeeney, S., Tognon, C. E. & Druker, B. J., Jan 1 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Open Access

Functional characterization of two rare BCR-FGFR1+ leukemias

Barnes, E. J., Leonard, J., Medeiros, B. C., Druker, B. J. & Tognon, C. E., Apr 1 2020, In : Cold Spring Harbor Molecular Case Studies. 6, 2

Research output: Contribution to journalArticle

Open Access

NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells

Fenerich, B. A., Fernandes, J. C., Rodrigues Alves, A. P. N., Coelho-Silva, J. L., Scopim-Ribeiro, R., Scheucher, P. S., Eide, C. A., Tognon, C. E., Druker, B. J., Rego, E. M., Machado-Neto, J. A. & Traina, F., Dec 1 2020, In : Signal Transduction and Targeted Therapy. 5, 1, 5.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Response and Resistance to BCR-ABL1-Targeted Therapies

Braun, T. P., Eide, C. A. & Druker, B. J., Apr 13 2020, In : Cancer Cell. 37, 4, p. 530-542 13 p.

Research output: Contribution to journalReview article

2 Scopus citations

Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia

Lamble, A. J., Kosaka, Y., Laderas, T., Maffit, A., Kaempf, A., Brady, L. K., Wang, W., Long, N., Saultz, J. N., Mori, M., Soong, D., LeFave, C. V., Huang, F., Adams, H., Loriaux, M. M., Loriaux, M. M., Tognon, C. E., Lo, P., Tyner, J. W., Tyner, J. W. & 8 others, Fan, G., McWeeney, S. K., Druker, B. J., Druker, B. J., Druker, B. J., Lind, E. F., Lind, E. F. & Lind, E. F., Jun 23 2020, In : Proceedings of the National Academy of Sciences of the United States of America. 117, 25, p. 14331-14341 11 p.

Research output: Contribution to journalArticle

Open Access

Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia

Eide, C. A., Kurtz, S. E., Kaempf, A., Long, N., Agarwal, A., Tognon, C. E., Mori, M., Druker, B. J., Chang, B. H., Danilov, A. V. & Tyner, J. W., Jan 1 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

1 Scopus citations
2019

Challenges and approaches to implementing master/basket trials in oncology

Burd, A., Schilsky, R. L., Byrd, J. C., Levine, R. L., Papadimitrakopoulou, V. A., Herbst, R. S., Redman, M. W., Druker, B. J. & Gandara, D. R., Jul 23 2019, In : Blood Advances. 3, 14, p. 2237-2243 7 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms

Zhang, H., Savage, S., Schultz, A. R., Bottomly, D., White, L., Segerdell, E., Wilmot, B., McWeeney, S. K., Eide, C. A., Nechiporuk, T., Carlos, A., Henson, R., Lin, C., Searles, R., Ho, H., Lam, Y. L., Sweat, R., Follit, C., Jain, V., Lind, E. & 10 others, Borthakur, G., Garcia-Manero, G., Ravandi, F., Kantarjian, H. M., Cortes, J., Collins, R., Buelow, D. R., Baker, S. D., Druker, B. J. & Tyner, J. W., Dec 1 2019, In : Nature communications. 10, 1, 244.

Research output: Contribution to journalArticle

20 Scopus citations

Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants

Eide, C. A., Zabriskie, M. S., Savage Stevens, S. L., Antelope, O., Vellore, N. A., Than, H., Schultz, A. R., Clair, P., Bowler, A. D., Pomicter, A. D., Yan, D., Senina, A. V., Qiang, W., Kelley, T. W., Szankasi, P., Heinrich, M. C., Tyner, J. W., Rea, D., Cayuela, J. M., Kim, D. W. & 4 others, Tognon, C. E., O'Hare, T., Druker, B. J. & Deininger, M. W., Oct 14 2019, In : Cancer Cell. 36, 4, p. 431-443.e5

Research output: Contribution to journalArticle

14 Scopus citations

Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemia

Agarwal, A., Bolosky, W. J., Wilson, D. B., Eide, C. A., Olson, S. B., Fan, G. & Druker, B. J., Dec 3 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 49, p. 24593-24599 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

Erratum: Correction: FGF2-FGFR1 signaling regulates release of leukemia-protective exosomes from bone marrow stromal cells (eLife (2019) 8 PII: e47174)

Javidi-Sharifi, N., Martinez, J., English, I., Joshi, S. K., Scopim-Ribeiro, R., Viola, S. K., Edwards, D. K., Agarwal, A., Lopez, C., Jorgens, D., Tyner, J. W., Druker, B. J. & Traer, E., Mar 29 2019, In : eLife. 8, e47174.

Research output: Contribution to journalComment/debate

Open Access

FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells

Javidi-Sharifi, N., Martinez, J., English, I., Joshi, S. K., Scopim-Ribiero, R., Edwards, D. K., Agarwal, A., Lopez, C., Jorgens, D., Tyner, J., Druker, B. & Traer, E., Feb 5 2019, In : eLife. 8

Research output: Contribution to journalArticle

Open Access
7 Scopus citations

Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

Zhang, H., Wilmot, B., Bottomly, D., Dao, K-H., Stevens, E., Eide, C. A., Khanna, V., Rofelty, A., Savage, S., Schultz, A. R., Long, N., White, L., Carlos, A., Henson, R., Lin, C., Searles, R., Collins, R. H., DeAngelo, D. J., Deininger, M. W., Dunn, T. & 12 others, Hein, T., Luskin, M. R., Medeiros, B. C., Oh, S. T., Pollyea, D. A., Steensma, D. P., Stone, R. M., Druker, B., McWeeney, S., Maxson, J. E., Gotlib, J. R. & Tyner, J., Sep 12 2019, In : Blood. 134, 11, p. 867-879 13 p.

Research output: Contribution to journalArticle

7 Scopus citations

Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia

on behalf of the International CML Foundation Genomics Alliance, Jan 1 2019, In : Leukemia.

Research output: Contribution to journalReview article

14 Scopus citations

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Braun, T. P., Okhovat, M., Coblentz, C., Carratt, S. A., Foley, A., Schonrock, Z., Smith, B. M., Nevonen, K., Davis, B., Garcia, B., LaTocha, D., Weeder, B. R., Grzadkowski, M. R., Estabrook, J. C., Manning, H. G., Watanabe-Smith, K., Jeng, S., Smith, J. L., Leonti, A. R., Ries, R. E. & 8 others, McWeeney, S., Di Genua, C., Drissen, R., Nerlov, C., Meshinchi, S., Carbone, L., Druker, B. J. & Maxson, J. E., Dec 1 2019, In : Nature communications. 10, 1, 5455.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Predicting response to BET inhibitors using computational modeling: A BEAT AML project study

Drusbosky, L. M., Vidva, R., Gera, S., Lakshminarayana, A. V., Shyamasundar, V. P., Agrawal, A. K., Talawdekar, A., Abbasi, T., Vali, S., Tognon, C. E., Kurtz, S. E., Tyner, J., McWeeney, S., Druker, B. & Cogle, C. R., Feb 1 2019, In : Leukemia Research. 77, p. 42-50 9 p.

Research output: Contribution to journalArticle

1 Scopus citations

Replication timing alterations in leukemia affect clinically relevant chromosome domains

Rivera-Mulia, J. C., Sasaki, T., Trevilla-Garcia, C., Nakamichi, N., Knapp, D. J. H. F., Hammond, C. A., Chang, B. H., Tyner, J. W., Devidas, M., Zimmerman, J., Klein, K. N., Somasundaram, V., Druker, B. J., Gruber, T. A., Koren, A., Eaves, C. J. & Gilbert, D. M., Nov 12 2019, In : Blood Advances. 3, 21, p. 3201-3213 13 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Reply to n. Cerveira et al

Berman, E., Druker, B. J. & Burwick, R., Jan 1 2019, In : Journal of Clinical Oncology. 37, 1, 1 p.

Research output: Contribution to journalLetter

Revisiting NTRKs as an emerging oncogene in hematological malignancies

Joshi, S. K., Davare, M. A., Druker, B. J. & Tognon, C. E., Nov 1 2019, In : Leukemia. 33, 11, p. 2563-2574 12 p.

Research output: Contribution to journalReview article

Open Access
3 Scopus citations

Targeting BCR-ABL1 in chronic myeloid leukemia by PROTAC-mediated targeted protein degradation

Burslem, G. M., Schultz, A. R., Bondeson, D. P., Eide, C. A., Stevens, S. L. S., Druker, B. J. & Crews, C. M., Sep 15 2019, In : Cancer Research. 79, 18, p. 4744-4753 10 p.

Research output: Contribution to journalArticle

12 Scopus citations

The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML

Dunlap, J. B., Leonard, J., Rosenberg, M., Cook, R., Press, R., Fan, G., Raess, P. W., Druker, B. J. & Traer, E., Aug 2019, In : American Journal of Hematology. 94, 8, p. 913-920 8 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells

Nechiporuk, T., Kurtz, S. E., Nikolova, O., Liu, T., Jones, C. L., D’alessandro, A., Culp-Hill, R., D’almeida, A., Joshi, S. K., Rosenberg, M., Tognon, C. E., Danilov, A. V., Druker, B. J., Chang, B. H., McWeeney, S. K. & Tyner, J. W., Jul 2019, In : Cancer discovery. 9, 7, p. 910-925 16 p.

Research output: Contribution to journalArticle

20 Scopus citations

Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib

Latifi, Y., Moccetti, F., Wu, M., Xie, A., Packwood, W., Qi, Y., Ozawa, K., Shentu, W., Brown, E., Shirai, T., McCarty, O. J., Ruggeri, Z., Moslehi, J., Chen, J., Druker, B. J., López, J. A. & Lindner, J. R., Apr 4 2019, In : Blood. 133, 14, p. 1597-1606 10 p.

Research output: Contribution to journalArticle

16 Scopus citations
2018

A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia

Zabriskie, M. S., Antelope, O., Verma, A. R., Draper, L. R., Eide, C. A., Pomicter, A. D., Tran, T. H., Druker, B., Tyner, J., Miles, R. R., Graham, J. M., Hwang, J. Y., Varley, K. E., Toydemir, R. M., Deininger, M. W., Raetz, E. A. & O’Hare, T., Jan 31 2018, In : Haematologica. 103, 2, p. e87-e91

Research output: Contribution to journalComment/debate

4 Scopus citations

Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia

Watanabe-Smith, K., Druker, B. J., Tyner, J. W. & Edwards, D. K., Jul 31 2018, In : Haematologica. 103, 8, p. e351-e355

Research output: Contribution to journalLetter

1 Scopus citations

Chronic myelogenous leukemia: Pregnancy in the era of stopping tyrosine kinase inhibitor therapy

Berman, E., Druker, B. J. & Burwick, R., Apr 20 2018, In : Journal of Clinical Oncology. 36, 12, p. 1250-1256 7 p.

Research output: Contribution to journalReview article

13 Scopus citations

Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia

Kurtz, S. E., Eide, C. A., Kaempf, A., Mori, M., Tognon, C. E., Borate, U., Druker, B. J. & Tyner, J. W., Sep 1 2018, In : Leukemia. 32, 9, p. 2025-2028 4 p.

Research output: Contribution to journalArticle

2 Scopus citations

Functional genomic landscape of acute myeloid leukaemia

Tyner, J. W., Tognon, C. E., Bottomly, D., Wilmot, B., Kurtz, S. E., Savage, S. L., Long, N., Schultz, A. R., Traer, E., Abel, M., Agarwal, A., Blucher, A., Borate, U., Bryant, J., Burke, R., Carlos, A., Carpenter, R., Carroll, J., Chang, B. H., Coblentz, C. & 68 others, d’Almeida, A., Cook, R., Danilov, A., Dao, K. H. T., Degnin, M., Devine, D., Dibb, J., Edwards, D. K., Eide, C. A., English, I., Glover, J., Henson, R., Ho, H., Jemal, A., Johnson, K., Johnson, R., Junio, B., Kaempf, A., Leonard, J., Lin, C., Liu, S. Q., Lo, P., Loriaux, M. M., Luty, S., Macey, T., MacManiman, J., Martinez, J., Mori, M., Nelson, D., Nichols, C., Peters, J., Ramsdill, J., Rofelty, A., Schuff, R., Searles, R., Segerdell, E., Smith, R. L., Spurgeon, S. E., Sweeney, T., Thapa, A., Visser, C., Wagner, J., Watanabe-Smith, K., Werth, K., Wolf, J., White, L., Yates, A., Zhang, H., Cogle, C. R., Collins, R. H., Connolly, D. C., Deininger, M. W., Drusbosky, L., Hourigan, C. S., Jordan, C. T., Kropf, P., Lin, T. L., Martinez, M. E., Medeiros, B. C., Pallapati, R. R., Pollyea, D. A., Swords, R. T., Watts, J. M., Weir, S. J., Wiest, D. L., Winters, R. M., McWeeney, S. K. & Druker, B. J., Oct 25 2018, In : Nature. 562, 7728, p. 526-531 6 p.

Research output: Contribution to journalArticle

122 Scopus citations

Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes

Hosseini, M. M., Kurtz, S. E., Abdelhamed, S., Mahmood, S., Davare, M. A., Kaempf, A., Elferich, J., McDermott, J. E., Liu, T., Payne, S. H., Shinde, U., Rodland, K. D., Mori, M., Druker, B. J., Singer, J. W. & Agarwal, A., Nov 1 2018, In : Leukemia. 32, 11, p. 2374-2387 14 p.

Research output: Contribution to journalArticle

8 Scopus citations

Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms

MacHado-Neto, J. A., Fenerich, B. A., Scopim-Ribeiro, R., Eide, C. A., Coelho-Silva, J. L., Dechandt, C. R. P., Fernandes, J. C., Rodrigues Alves, A. P. N., Scheucher, P. S., Simões, B. P., Alberici, L. C., De Figueiredo Pontes, L. L., Tognon, C. E., Druker, B., Rego, E. M. & Traina, F., Mar 1 2018, In : Cell Death and Disease. 9, 3, 311.

Research output: Contribution to journalArticle

5 Scopus citations

Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma

Davare, M. A., Henderson, J. J., Agarwal, A., Wagner, J. P., Iyer, S. R., Shah, N., Woltjer, R., Somwar, R., Gilheeney, S. W., DeCarvalo, A., Mikkelson, T., Van Meir, E. G., Ladanyi, M. & Druker, B. J., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6471-6482 12 p.

Research output: Contribution to journalArticle

8 Scopus citations

Reply to D.M. Ross et al and V. Florou et al

Berman, E., Druker, B. J. & Burwick, R., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2660-2661 2 p.

Research output: Contribution to journalLetter

Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition

Mitchell, R., Hopcroft, L. E. M., Baquero, P., Allan, E. K., Hewit, K., James, D., Hamilton, G., Mukhopadhyay, A., O'Prey, J., Hair, A., Melo, J. V., Chan, E., Ryan, K. M., Maguer-Satta, V., Druker, B. J., Clark, R. E., Mitra, S., Herzyk, P., Nicolini, F. E., Salomoni, P. & 4 others, Shanks, E., Calabretta, B., Holyoake, T. L. & Helgason, G. V., 2018, In : Journal of the National Cancer Institute. 110, 5, p. 467-478 12 p.

Research output: Contribution to journalArticle

25 Scopus citations

Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples

Edwards V, D. K., Sweeney, D. T., Ho, H., Eide, C. A., Rofelty, A., Agarwal, A., Liu, S. Q., Danilov, A. V., Lee, P., Chantry, D., McWeeney, S. K., Druker, B. J., Tyner, J. W., Spurgeon, S. E. & Loriaux, M. M., May 15 2018, In : Oncotarget. 9, 37, p. 24576-24589 14 p.

Research output: Contribution to journalArticle

12 Scopus citations
2017

Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: Findings and recommendations

Watanabe-Smith, K., Godil, J., Agarwal, A., Tognon, C. & Druker, B., 2017, In : Oncotarget. 8, 8, p. 12596-12606 11 p.

Research output: Contribution to journalArticle

5 Scopus citations

CRISPR-Cas9–mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy

Ma, L., Boucher, J. I., Paulsen, J., Matuszewski, S., Eide, C. A., Ou, J., Eickelberg, G., Press, R. D., Zhu, L. J., Druker, B. J., Branford, S., Wolfe, S. A., Jensen, J. D., Schiffer, C. A., Green, M. R. & Bolon, D. N., Oct 31 2017, In : Proceedings of the National Academy of Sciences of the United States of America. 114, 44, p. 11751-11756 6 p.

Research output: Contribution to journalArticle

16 Scopus citations

Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors

Pietarinen, P. O., Eide, C. A., Ayuda-Durán, P., Potdar, S., Kuusanmäki, H., Andersson, E. I., Mpindi, J. P., Pemovska, T., Kontro, M., Heckman, C. A., Kallioniemi, O., Wennerberg, K., Hjorth-Hansen, H., Druker, B. J., Enserink, J. M., Tyner, J. W., Mustjoki, S. & Porkka, K., 2017, In : Oncotarget. 8, 14, p. 22606-22615 10 p.

Research output: Contribution to journalArticle

4 Scopus citations

EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT

Merchant, A. A., Jorapur, A., McManus, A., Liu, R., Krasnoperov, V., Chaudhry, P., Singh, M., Harton, L., Agajanian, M., Kim, M., Triche, T. J., Druker, B. J., Tyner, J. W. & Gill, P. S., Sep 12 2017, In : Blood Advances. 1, 20, p. 1635-1644 10 p.

Research output: Contribution to journalArticle

Open Access
12 Scopus citations

Foreword

Druker, B. J., Jan 1 2017, Oral, Head and Neck Oncology and Reconstructive Surgery. Elsevier, p. xvii

Research output: Chapter in Book/Report/Conference proceedingForeword/postscript

Functional validation of the oncogenic cooperativity and targeting potential of tuberous sclerosis mutation in medulloblastoma using a MYC-amplified model cell line

Henderson, J. J., Wagner, J. P., Hofmann, N. E., Eide, C. A., Cho, Y-J., Druker, B. & Davare, M., 2017, (Accepted/In press) In : Pediatric Blood and Cancer.

Research output: Contribution to journalArticle

2 Scopus citations

Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia

Carey, A., Edwards, D. K., Eide, C. A., Newell, L., Traer, E., Medeiros, B. C., Pollyea, D. A., Deininger, M. W., Collins, R. H., Tyner, J., Druker, B., Bagby, G. C., McWeeney, S. & Agarwal, A., Mar 28 2017, In : Cell Reports. 18, 13, p. 3204-3218 15 p.

Research output: Contribution to journalArticle

55 Scopus citations

Long-term outcomes of imatinib treatment for chronic myeloid leukemia

Hochhaus, A., Larson, R. A., Guilhot, F., Radich, J. P., Branford, S., Hughes, T. P., Baccarani, M., Deininger, M. W., Cervantes, F., Fujihara, S., Ortmann, C. E., Menssen, H. D., Kantarjian, H., O'Brien, S. G. & Druker, B. J., Mar 9 2017, In : New England Journal of Medicine. 376, 10, p. 917-927 11 p.

Research output: Contribution to journalArticle

335 Scopus citations

Maternal, fetal, and neonatal imatinib levels with treatment of chronic myeloid leukemia in pregnancy

Burwick, R., Kuo, K., Brewer, D. & Druker, B., 2017, In : Obstetrics and Gynecology. 129, 5, p. 831-834 4 p.

Research output: Contribution to journalArticle

6 Scopus citations

Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies

Kurtz, S. E., Eide, C. A., Kaempf, A., Khanna, V., Savage, S. L., Rofelty, A., English, I., Ho, H., Pandya, R., Bolosky, W. J., Poon, H., Deininger, M. W., Collins, R., Swords, R. T., Watts, J., Pollyea, D. A., Medeiros, B. C., Traer, E., Tognon, C. E., Mori, M. & 2 others, Druker, B. J. & Tyner, J. W., Sep 5 2017, In : Proceedings of the National Academy of Sciences of the United States of America. 114, 36, p. E7554-E7563

Research output: Contribution to journalArticle

39 Scopus citations

Novel Method Enabling the Use of Cryopreserved Primary Acute Myeloid Leukemia Cells in Functional Drug Screens

Degnin, M., Agarwal, A., Tarlock, K., Meshinchi, S., Druker, B. & Tognon, C. E., 2017, In : Journal of Pediatric Hematology/Oncology. 39, 7, p. e359-e366

Research output: Contribution to journalArticle

Peter C. Nowell (1928-2016)

Reed, J. C. & Druker, B. J., May 2 2017, In : Proceedings of the National Academy of Sciences of the United States of America. 114, 18, p. 4569-4570 2 p.

Research output: Contribution to journalArticle

Recurrent cyclin D2 mutations in myeloid neoplasms

Khanna, V., Eide, C. A., Tognon, C. E., Maxson, J., Wilmot, B., Bottomly, D., McWeeney, S., Edwards, V. D. K., Druker, B. & Tyner, J., Sep 1 2017, In : Leukemia. 31, 9, p. 2005-2008 4 p.

Research output: Contribution to journalLetter

3 Scopus citations